
IGF-1 LR3
1mg >99% purity Coa verified
CA$145.00
IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3) is a modified analog of insulin-like growth factor-1 designed with an extended half-life and reduced binding affinity to IGF-binding proteins. It has been studied in preclinical research for its roles in cellular growth signaling, protein synthesis pathways, and IGF-1 receptor interaction. IGF-1 LR3 is also investigated for its involvement in cell proliferation, differentiation, and anabolic signaling processes. A widely studied compound in growth factor and peptide research.
>99% Purity · Third-Party Tested · For Research Use Only. All products currently listed on this site are for research purposes only.
Matrix Peptides
FDA Disclaimer
All products sold by Matrix Peptides are intended strictly for laboratory research and development purposes only. These products are not intended for human consumption, injection, or diagnostic use.
The statements made on this website have not been evaluated by Health Canada or the U.S. Food and Drug Administration (FDA). The products offered are not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Matrix Peptides operates as a chemical supplier. We are not a licensed pharmacy, compounding pharmacy, or outsourcing facility as defined under applicable Canadian or United States regulations.
All products are intended for in-vitro and pre-clinical research use only. By purchasing from this website, the customer represents and warrants that
They are a qualified professional or researcher
They understand the nature of the products
They will use the products in compliance with all applicable laws and regulations
They have the proper training, facilities, and safety protocols in place
The customer acknowledges that there are inherent risks associated with the handling and use of research chemicals, and agrees that Matrix Peptides shall not be held liable for any misuse, improper handling, or use outside of intended research purposes.
Contact
Matrixpeps@gmail.com
